1333222-45-9 Usage
Uses
Used in Pharmaceutical Industry:
5-Fluoro-6-benzoxypyridine-3-boronic acid pinacol ester is used as a synthetic building block for the creation of pharmaceutical compounds. Its incorporation into various molecular structures facilitates the development of new drugs, enhancing the therapeutic potential of medicinal agents.
Used in Medicinal Chemistry Research:
As a reagent in medicinal chemistry, 5-Fluoro-6-benzoxypyridine-3-boronic acid pinacol ester is utilized for the introduction of its specific moiety into different molecules. This allows researchers to explore and synthesize novel biologically active compounds, contributing to the advancement of drug discovery and the identification of potential drug candidates.
Used in Organic Synthesis:
5-Fluoro-6-benzoxypyridine-3-boronic acid pinacol ester is employed as a key intermediate in organic synthesis processes. Its unique properties make it a useful component in the construction of complex organic molecules, which can be further utilized in various chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1333222-45-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,3,2,2 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1333222-45:
(9*1)+(8*3)+(7*3)+(6*3)+(5*2)+(4*2)+(3*2)+(2*4)+(1*5)=109
109 % 10 = 9
So 1333222-45-9 is a valid CAS Registry Number.
1333222-45-9Relevant academic research and scientific papers
ION CHANNEL MODULATORS
-
, (2019/12/25)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
